Focusing on prostate cancer, the major interest of our laboratory, Veltri and colleagues initially confirmed that serum CXCL8 levels correlated with prostate cancer stage, with the greatest levels detected in patients with metastatic prostate cancer [49]. This evidence concerns the gene CXCL8 and Familial prostate cancer.